Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Priority_List,Schedules,Therapeutic_group
"GlaxoSmithKline, GLAXOSMITHKLINE NZ LIMITED","Fluticasone with Vilanterol, 200/25, high dose, severe asthma",Asthma,"Fluticasone with Vilanterol, 200/25, high dose, severe asthma (Breo Ellipta)",Recommended for decline,Community and Hospital,Respiratory System and Allergies
